Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior

Journal of Investigative Dermatology

Volumn 111, Issue 6, 1998, Pages 1227-1231

  Büttner, Claudia ^a,d   Henz, Beate M ^a   Welker, Pia ^a   Sepp, Norbert T ^b   Grabbe, Jürgen ^c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF LÜBECK   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HMC 1; Mast cells; Stem cell factor; Urticaria pigmentosa

Indexed keywords

STEM CELL FACTOR;

ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; MALE; MAST CELL LEUKEMIA; MASTOCYTOSIS; MEDIATOR RELEASE; ONSET AGE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE; REMISSION; STEM CELL;

EID: 0032456567     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00414.x     Document Type: Article

References (37)

1. Anderson DM, Lyman SD, Baird A, et al: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms [Erratum, Cell 63:1112a, 1990]. Cell 63:235-243, 1990
2. Azana JM, Torrelo A, Mediero IG, Zambrano A: Urticaria pigmemosa; a review of 67 pediatric cases. Pediatr Dermatol 11:102-106, 1994
3. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 4:345-355, 1988
4. Chabot B, Stephenson DA, Capman VM, Besmer P, Bernstein A: The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88-89, 1988
5. Copeland NG, Gilbert DJ, Cho BC, et al: Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63:175-183, 1990
6. Costa JJ, Demetri GD, Harrist TJ, et al: Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681-2686, 1996
7. Czarnetzki BM, Behrendt H: Urticaria pigmentosa: Clinical picture and response to oral disodiumcromoglycate. Br J Dermatol 105:563-568, 1981
8. Czarnetzki BM, Kolde G, Schoemann A, Urbanitz S, Urbanitz D: Bone marrow findings in adult patients with urticaria pigmemosa. J Am Acad Dermatol 18:45-51, 1988
9. Czarnetzki BM, Grabbe J, Kolde G, Krüger-Krasagakes S, Zuberbier T: Mast cells in the cytokine network -the what, where from and what for. Exp Dermatol 4:221-226, 1995
10. Funasaka Y, Boulton T, Cobb M, et al: C-kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3:197-209, 1992
11. Furitsu T, Tsujimura T, Tono T, et al: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736-1744, 1993
12. Genovese A, Spadaro G, Triggiani M, Marone G: Clinical advances in mastocytosis. Int J Clin Lab Res 25:178-188, 1995
13. Golkar L, Bernhard JD: Mastocytosis. Lancet 349:1379-1385, 1997
14. Halaban R, Tyrrell L, Longley J, Yarden Y, Rubin J: Pigmentation and proliferation of human melanocytes and the effects of melanocyte-stimulating hormone and ultraviolet B light. Ann NY Acad Sci 680:290-301, 1993
15. Hamann K, Haas N, Grabbe J, Czarnetzki BM: Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 133:203-208, 1995
16. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD 34 bone marrow progenitor cell. J Immunol 146:1410-1415, 1991
17. Kishi K: A leukemic cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 9:381-390, 1985
18. Kitayama G, Kanakura Y, Furitsu T, et al: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790-798, 1995
19. Lishner M, Confino-Cohen R, Mekori YA, et al: Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol 98:199-204, 1996
20. Longley BJ, Morganroth GS, Tyrell BA: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302-1307, 1993
21. Longley BJ, Tyrrell L, Lu SZ, et al: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312-314, 1996
22. Metcalfe DD: Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 96:2S, 1991
23. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92:10560-10564, 1995
24. Nagata H, Okada T, Worobec AS, Semere T, Metcalfe DD: C-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 113:184-186, 1997
25. Piao X, Bernstein A: A point muration in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentation of mast cells. Blood 87:3117-3123, 1996
26. Piao X, Paulson R, van der Geer P, Pawson T, Bernstein A: Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phasphatase SHP-1. Proc Natl Acad Sci USA 93:14665-14669, 1996
27. Qiu F, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P: Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family - oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003-1011, 1988
28. Sagher F, Even-Paz Z: Mastocytosis and the Mast Cell. Chicago: Year Book Medical, 1967
29. Shibata D, Martin WJ, Arnheim N: Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res 48:4564-4566, 1988
30. Travis WD, Li C-Y, Bergstralh EF, Yam LT, Swee RG: Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine 67:345-368, 1988
31. Tsujimura T, Furitsu T, Morimoto M, et al: Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619-2626, 1994
32. Tsujimura T, Furitsu T, Morimoto M, et al: Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377-385, 1995
33. Tsujimura T, Kanakura Y, Kitamura Y: Mechanisms of constitutive activation of c-kit receptor tyrosine kinase. Leukemia 11:396-398, 1997
34. Valent P, Spanblochl E, Sperr WR, et al: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237-2245, 1992
35. Welker P, Grabbe J, Grützkau A, Henz BM: Effects of NGF and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunol 94:310-317, 1998
36. Yarden Y, Kuang WJ, Yang-Feng T, et al: Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
37. Zsebo KM, Wypych J, McNiece IK, et al: Identification, purification and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195-201, 1990